...
首页> 外文期刊>Brain research >Down-regulation of Nogo-A by collagen scaffolds impregnated with bone marrow stromal cell treatment after traumatic brain injury promotes axonal regeneration in rats
【24h】

Down-regulation of Nogo-A by collagen scaffolds impregnated with bone marrow stromal cell treatment after traumatic brain injury promotes axonal regeneration in rats

机译:脑外伤后胶原基质浸渍骨髓基质细胞处理后Nogo-A的下调促进了大鼠轴突再生

获取原文
获取原文并翻译 | 示例
           

摘要

Nogo-A is a major form of growth inhibitory molecule (growth-IM) which inhibits axonal regeneration and neurite regrowth after neural injury. Bone marrow stromal cells (MSCs) have been shown to inhibit Nogo-A expression in vitro and in cerebral ischemic animal models. The present study was designed to investigate the effects of treatment with human MSCs (hMSCs) impregnated into collagen scaffolds on the expression of Nogo-A and axonal plasticity after traumatic brain injury (TBI). Adult male Wistar rats were injured with controlled cortical impact and treated either with saline, hMSCs-alone or hMSCs impregnated into collagen scaffolds (scaffold+hMSC) transplanted into the lesion cavity 7 days after TBI. Rats were sacrificed 14 days after TBI and brain tissues were harvested for immunohistochemical studies, Western blot analysis, laser capture microdissections and qRT-PCR to evaluate axonal density and Nogo-A protein and gene expressions. Our data showed that treatment of TBI with scaffold+hMSC significantly decreased TBI-induced Nogo-A protein expression and increased axonal density compared to saline and hMSC-alone treatments. In addition, scaffold+hMSC transplantation decreased Nogo-A transcription in oligodendrocytes after TBI. Scaffold+hMSC treatment was superior to hMSC-alone treatment in suppressing Nogo-A expression and enhancing axonal regeneration after TBI. Our data suggest that transplanting hMSCs with scaffolds down-regulates Nogo-A transcription and protein expression which may partially contribute to the enhanced axonal regeneration after TBI.
机译:Nogo-A是生长抑制分子(growth-IM)的主要形式,其抑制神经损伤后的轴突再生和神经突再生。骨髓基质细胞(MSCs)已显示在体​​外和脑缺血动物模型中均能抑制Nogo-A表达。本研究旨在研究用胶原蛋白支架浸渍的人类MSCs对创伤性脑损伤(TBI)后Nogo-A表达和轴突可塑性的影响。成年雄性Wistar大鼠受到可控的皮层撞击伤害,并在TBI后7天用盐水,单独的hMSC或浸入胶原蛋白支架(scaffold + hMSC)的hMSCs处理,然后将其移植到病变腔中。 TBI 14天后处死大鼠,收集脑组织进行免疫组织化学研究,Western印迹分析,激光捕获显微切割和qRT-PCR以评估轴突密度以及Nogo-A蛋白和基因表达。我们的数据显示,与单独使用生理盐水和hMSC的治疗相比,用支架+ hMSC治疗TBI显着降低了TBI诱导的Nogo-A蛋白表达并增加了轴突密度。此外,支架+ hMSC移植可减少TBI后少突胶质细胞中的Nogo-A转录。在抑制Nogo-A表达并增强TBI后轴突再生方面,支架+ hMSC治疗优于仅hMSC治疗。我们的数据表明用支架移植hMSCs下调Nogo-A转录和蛋白表达,这可能部分有助于TBI后轴突再生的增强。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号